Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Alimta Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Alimta Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-09-06

Pages: 71 Pages

Report ld: 5030030

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Alimta market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Alimta market competitiveness, regional economic performance, and supply chain configurations.

Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

The North America Alimta market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key manufacturers of Alimta include Eli Lilly, Abbott Healthcare, Cadila Healthcare, Eagle Pharmaceuticals, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Alimta market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

By Company

Eli Lilly
Abbott Healthcare
Cadila Healthcare
Eagle Pharmaceuticals

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

100mg
500mg

Segment by Application

Pleural Mesothelioma
Non-small Cell Lung Cancer

biaoTi Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Alimta market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., 500mg in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Non-small Cell Lung Cancer in India).

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

Why This Report?

This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:

- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).

- Product Portfolio Optimization: Align offerings with regional preferences (e.g., 100mg dominance in Europe vs. 500mg demand in MEA).

- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

biaoTi QYResearch's Strengths

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Market Overview

1.1 Alimta Product Scope

1.2 Alimta by Type

1.2.1 Global Alimta Sales by Type (2020 & 2024 & 2031)

1.2.2 100mg

1.2.3 500mg

1.3 Alimta by Application

1.3.1 Global Alimta Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Pleural Mesothelioma

1.3.3 Non-small Cell Lung Cancer

1.4 Global Alimta Market Estimates and Forecasts (2020-2031)

1.4.1 Global Alimta Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Alimta Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Alimta Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Alimta Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Alimta Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Alimta Sales Market Share by Region (2020-2025)

2.2.2 Global Alimta Revenue Market Share by Region (2020-2025)

2.3 Global Alimta Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Alimta Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Alimta Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Alimta Market Size and Prospective (2020-2031)

2.4.2 Europe Alimta Market Size and Prospective (2020-2031)

2.4.3 China Alimta Market Size and Prospective (2020-2031)

2.4.4 Japan Alimta Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Alimta Historic Market Review by Type (2020-2025)

3.1.1 Global Alimta Sales by Type (2020-2025)

3.1.2 Global Alimta Revenue by Type (2020-2025)

3.1.3 Global Alimta Price by Type (2020-2025)

3.2 Global Alimta Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Alimta Sales Forecast by Type (2026-2031)

3.2.2 Global Alimta Revenue Forecast by Type (2026-2031)

3.2.3 Global Alimta Price Forecast by Type (2026-2031)

3.3 Different Types Alimta Representative Players

4 Global Market Size by Application

4.1 Global Alimta Historic Market Review by Application (2020-2025)

4.1.1 Global Alimta Sales by Application (2020-2025)

4.1.2 Global Alimta Revenue by Application (2020-2025)

4.1.3 Global Alimta Price by Application (2020-2025)

4.2 Global Alimta Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Alimta Sales Forecast by Application (2026-2031)

4.2.2 Global Alimta Revenue Forecast by Application (2026-2031)

4.2.3 Global Alimta Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Alimta Application

5 Competition Landscape by Players

5.1 Global Alimta Sales by Players (2020-2025)

5.2 Global Top Alimta Players by Revenue (2020-2025)

5.3 Global Alimta Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alimta as of 2024)

5.4 Global Alimta Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Alimta, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Alimta, Product Type & Application

5.7 Global Key Manufacturers of Alimta, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Alimta Sales by Company

6.1.1.1 North America Alimta Sales by Company (2020-2025)

6.1.1.2 North America Alimta Revenue by Company (2020-2025)

6.1.2 North America Alimta Sales Breakdown by Type (2020-2025)

6.1.3 North America Alimta Sales Breakdown by Application (2020-2025)

6.1.4 North America Alimta Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Alimta Sales by Company

6.2.1.1 Europe Alimta Sales by Company (2020-2025)

6.2.1.2 Europe Alimta Revenue by Company (2020-2025)

6.2.2 Europe Alimta Sales Breakdown by Type (2020-2025)

6.2.3 Europe Alimta Sales Breakdown by Application (2020-2025)

6.2.4 Europe Alimta Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Alimta Sales by Company

6.3.1.1 China Alimta Sales by Company (2020-2025)

6.3.1.2 China Alimta Revenue by Company (2020-2025)

6.3.2 China Alimta Sales Breakdown by Type (2020-2025)

6.3.3 China Alimta Sales Breakdown by Application (2020-2025)

6.3.4 China Alimta Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Alimta Sales by Company

6.4.1.1 Japan Alimta Sales by Company (2020-2025)

6.4.1.2 Japan Alimta Revenue by Company (2020-2025)

6.4.2 Japan Alimta Sales Breakdown by Type (2020-2025)

6.4.3 Japan Alimta Sales Breakdown by Application (2020-2025)

6.4.4 Japan Alimta Major Customer

6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Eli Lilly

7.1.1 Eli Lilly Company Information

7.1.2 Eli Lilly Business Overview

7.1.3 Eli Lilly Alimta Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Eli Lilly Alimta Products Offered

7.1.5 Eli Lilly Recent Development

7.2 Abbott Healthcare

7.2.1 Abbott Healthcare Company Information

7.2.2 Abbott Healthcare Business Overview

7.2.3 Abbott Healthcare Alimta Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Abbott Healthcare Alimta Products Offered

7.2.5 Abbott Healthcare Recent Development

7.3 Cadila Healthcare

7.3.1 Cadila Healthcare Company Information

7.3.2 Cadila Healthcare Business Overview

7.3.3 Cadila Healthcare Alimta Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Cadila Healthcare Alimta Products Offered

7.3.5 Cadila Healthcare Recent Development

7.4 Eagle Pharmaceuticals

7.4.1 Eagle Pharmaceuticals Company Information

7.4.2 Eagle Pharmaceuticals Business Overview

7.4.3 Eagle Pharmaceuticals Alimta Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Eagle Pharmaceuticals Alimta Products Offered

7.4.5 Eagle Pharmaceuticals Recent Development

8 Alimta Manufacturing Cost Analysis

8.1 Alimta Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Alimta

8.4 Alimta Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Alimta Distributors List

9.3 Alimta Customers

10 Alimta Market Dynamics

10.1 Alimta Industry Trends

10.2 Alimta Market Drivers

10.3 Alimta Market Challenges

10.4 Alimta Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

Table of Figures

List of Tables

Table 1. Global Alimta Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Alimta Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Alimta Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Alimta Sales (Kg) by Region (2020-2025)

Table 5. Global Alimta Sales Market Share by Region (2020-2025)

Table 6. Global Alimta Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Alimta Revenue Share by Region (2020-2025)

Table 8. Global Alimta Sales (Kg) Forecast by Region (2026-2031)

Table 9. Global Alimta Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Alimta Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Alimta Revenue Share Forecast by Region (2026-2031)

Table 12. Global Alimta Sales by Type (Kg) & (2020-2025)

Table 13. Global Alimta Sales Share by Type (2020-2025)

Table 14. Global Alimta Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Alimta Price by Type (USD/g) & (2020-2025)

Table 16. Global Alimta Sales by Type (Kg) & (2026-2031)

Table 17. Global Alimta Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Alimta Price by Type (USD/g) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Alimta Sales by Application (Kg) & (2020-2025)

Table 21. Global Alimta Sales Share by Application (2020-2025)

Table 22. Global Alimta Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Alimta Price by Application (USD/g) & (2020-2025)

Table 24. Global Alimta Sales by Application (Kg) & (2026-2031)

Table 25. Global Alimta Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Alimta Price by Application (USD/g) & (2026-2031)

Table 27. New Sources of Growth in Alimta Application

Table 28. Global Alimta Sales by Company (Kg) & (2020-2025)

Table 29. Global Alimta Sales Share by Company (2020-2025)

Table 30. Global Alimta Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Alimta Revenue Share by Company (2020-2025)

Table 32. Global Alimta by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alimta as of 2024)

Table 33. Global Market Alimta Average Price by Company (USD/g) & (2020-2025)

Table 34. Global Key Manufacturers of Alimta, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Alimta, Product Type & Application

Table 36. Global Key Manufacturers of Alimta, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Alimta Sales by Company (2020-2025) & (Kg)

Table 39. North America Alimta Sales Market Share by Company (2020-2025)

Table 40. North America Alimta Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Alimta Revenue Market Share by Company (2020-2025)

Table 42. North America Alimta Sales by Type (2020-2025) & (Kg)

Table 43. North America Alimta Sales Market Share by Type (2020-2025)

Table 44. North America Alimta Sales by Application (2020-2025) & (Kg)

Table 45. North America Alimta Sales Market Share by Application (2020-2025)

Table 46. Europe Alimta Sales by Company (2020-2025) & (Kg)

Table 47. Europe Alimta Sales Market Share by Company (2020-2025)

Table 48. Europe Alimta Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Alimta Revenue Market Share by Company (2020-2025)

Table 50. Europe Alimta Sales by Type (2020-2025) & (Kg)

Table 51. Europe Alimta Sales Market Share by Type (2020-2025)

Table 52. Europe Alimta Sales by Application (2020-2025) & (Kg)

Table 53. Europe Alimta Sales Market Share by Application (2020-2025)

Table 54. China Alimta Sales by Company (2020-2025) & (Kg)

Table 55. China Alimta Sales Market Share by Company (2020-2025)

Table 56. China Alimta Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Alimta Revenue Market Share by Company (2020-2025)

Table 58. China Alimta Sales by Type (2020-2025) & (Kg)

Table 59. China Alimta Sales Market Share by Type (2020-2025)

Table 60. China Alimta Sales by Application (2020-2025) & (Kg)

Table 61. China Alimta Sales Market Share by Application (2020-2025)

Table 62. Japan Alimta Sales by Company (2020-2025) & (Kg)

Table 63. Japan Alimta Sales Market Share by Company (2020-2025)

Table 64. Japan Alimta Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Alimta Revenue Market Share by Company (2020-2025)

Table 66. Japan Alimta Sales by Type (2020-2025) & (Kg)

Table 67. Japan Alimta Sales Market Share by Type (2020-2025)

Table 68. Japan Alimta Sales by Application (2020-2025) & (Kg)

Table 69. Japan Alimta Sales Market Share by Application (2020-2025)

Table 70. Eli Lilly Company Information

Table 71. Eli Lilly Description and Business Overview

Table 72. Eli Lilly Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 73. Eli Lilly Alimta Product

Table 74. Eli Lilly Recent Development

Table 75. Abbott Healthcare Company Information

Table 76. Abbott Healthcare Description and Business Overview

Table 77. Abbott Healthcare Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 78. Abbott Healthcare Alimta Product

Table 79. Abbott Healthcare Recent Development

Table 80. Cadila Healthcare Company Information

Table 81. Cadila Healthcare Description and Business Overview

Table 82. Cadila Healthcare Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 83. Cadila Healthcare Alimta Product

Table 84. Cadila Healthcare Recent Development

Table 85. Eagle Pharmaceuticals Company Information

Table 86. Eagle Pharmaceuticals Description and Business Overview

Table 87. Eagle Pharmaceuticals Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 88. Eagle Pharmaceuticals Alimta Product

Table 89. Eagle Pharmaceuticals Recent Development

Table 90. Production Base and Market Concentration Rate of Raw Material

Table 91. Key Suppliers of Raw Materials

Table 92. Alimta Distributors List

Table 93. Alimta Customers List

Table 94. Alimta Market Trends

Table 95. Alimta Market Drivers

Table 96. Alimta Market Challenges

Table 97. Alimta Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Alimta Product Picture

Figure 2. Global Alimta Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Alimta Sales Market Share by Type in 2024 & 2031

Figure 4. 100mg Product Picture

Figure 5. 500mg Product Picture

Figure 6. Global Alimta Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Alimta Sales Market Share by Application in 2024 & 2031

Figure 8. Pleural Mesothelioma Examples

Figure 9. Non-small Cell Lung Cancer Examples

Figure 10. Global Alimta Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Alimta Sales Growth Rate (2020-2031) & (US$ Million)

Figure 12. Global Alimta Sales (Kg) Growth Rate (2020-2031)

Figure 13. Global Alimta Price Trends Growth Rate (2020-2031) & (USD/g)

Figure 14. Alimta Report Years Considered

Figure 15. Global Market Alimta Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 16. Global Alimta Revenue Market Share by Region: 2020 VS 2024

Figure 17. North America Alimta Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. North America Alimta Sales (Kg) Growth Rate (2020-2031)

Figure 19. Europe Alimta Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Europe Alimta Sales (Kg) Growth Rate (2020-2031)

Figure 21. China Alimta Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. China Alimta Sales (Kg) Growth Rate (2020-2031)

Figure 23. Japan Alimta Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. Japan Alimta Sales (Kg) Growth Rate (2020-2031)

Figure 25. Global Alimta Revenue Share by Type (2020-2025)

Figure 26. Global Alimta Sales Share by Type (2026-2031)

Figure 27. Global Alimta Revenue Share by Type (2026-2031)

Figure 28. Global Alimta Revenue Share by Application (2020-2025)

Figure 29. Global Alimta Revenue Growth Rate by Application in 2020 & 2024

Figure 30. Global Alimta Sales Share by Application (2026-2031)

Figure 31. Global Alimta Revenue Share by Application (2026-2031)

Figure 32. Global Alimta Sales Share by Company (2024)

Figure 33. Global Alimta Revenue Share by Company (2024)

Figure 34. Global 5 Largest Alimta Players Market Share by Revenue in Alimta: 2020 & 2024

Figure 35. Alimta Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 36. Manufacturing Cost Structure of Alimta

Figure 37. Manufacturing Process Analysis of Alimta

Figure 38. Alimta Industrial Chain

Figure 39. Channels of Distribution (Direct Vs Distribution)

Figure 40. Distributors Profiles

Figure 41. Bottom-up and Top-down Approaches for This Report

Figure 42. Data Triangulation

Figure 43. Key Executives Interviewed

Related Reports

Global Alimta Market Research Report 2024
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-01-04
Pages: 74
USD 2900.00
(Single User License)
Alimta - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-01-24
Pages: 85
USD 3950.00
(Single User License)
Global Alimta Market Insights, Forecast to 2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-04-15
Pages: 76
USD 4900.00
(Single User License)
Global Alimta Market Research Report 2025
The global market for Alimta was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 69
USD 2900.00
(Single User License)
Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Alimta was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 85
USD 3950.00
(Single User License)
Global Alimta Market Research Report 2026
The global Alimta market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 97
USD 2900.00
(Single User License)
Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Alimta was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 122
USD 3950.00
(Single User License)

Global Alimta Market Research Report 2024
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-01-04
Pages: 74
USD 2900.00 (Single User License)
Alimta - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-01-24
Pages: 85
USD 3950.00 (Single User License)
Global Alimta Market Insights, Forecast to 2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-04-15
Pages: 76
USD 4900.00 (Single User License)
Global Alimta Market Research Report 2025
The global market for Alimta was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 69
USD 2900.00 (Single User License)
Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Alimta was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 85
USD 3950.00 (Single User License)
Global Alimta Market Research Report 2026
The global Alimta market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 97
USD 2900.00 (Single User License)
Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Alimta was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 122
USD 3950.00 (Single User License)